본문영역
-
Hospital
Ajou saves end-stage heart failure patient with LVAD implantation
Ajou University Hospital said Thursday that it had successfully implanted a left ventricular assist device (LVAD) in a patient with end-stage heart failure.The patient, a man in hi...
Kwak Sung-sun
2026-06-04 4:20 PM
-
Pharma
J&J Innovative Medicine Korea wins reimbursement for Darzalex SC regimen...
Johnson & Johnson (J&J) Innovative Medicine Korea said Darzalex subcutaneous injection-based quadruple regimen has received reimbursement in Korea as a first-line treatment for new...
Lee Han-soo
2026-06-04 2:07 PM
-
Bio
LigaChem's partner SOTIO wins FDA orphan drug status for osteosarcoma ADC
LigaChem Biosciences said Thursday that its Czech partner SOTIO Biotech has received orphan drug designation from the FDA for SOT106, an LRRC15-targeting antibody-drug conjugate (A...
Lee Han-soo
2026-06-04 10:32 AM
-
Hospital
'PDRN injection improves outcomes in surgery for Crohn’s disease-related anal fistulas'
Researchers at Asan Medical Center (AMC) reported that local injection of polydeoxyribonucleotide (PDRN) during surgery for Crohn’s disease-related anal fistulas increased the cure...
Kwak Sung-sun
2026-06-04 4:50 PM
-
Pharma
Samjin adds 3mg donepezil option to Alzheimer’s treatment lineup
Samjin Pharmaceutical said Tuesday that it has launched Neutoin Tablets 3mg (donepezil hydrochloride), a low-dose treatment for Alzheimer's disease.According to the company, patien...
Kim Ji-hye
2026-06-04 2:53 PM
-
Policy
Korea to broaden life-sustaining treatment decisions beyond end-of-life stage
The government plans to expand the point at which life-sustaining treatment can be withheld or withdrawn from the current end-of-life stage to include terminally ill patients, whil...
Kim Jung-hyun
2026-06-04 3:11 PM
-
Policy
MFDS designates 3 cancer and anesthesia drugs as essential medicines
The Ministry of Food and Drug Safety (MFDS) announced Tuesday that it has designated three injectable medicines as national essential medicines: dacarbazine injection, doxorubicin ...
Kim Ji-hye
2026-06-04 2:27 PM
-
Bio
After MASH phase 2 win, D&D Pharmatech founders commit to 2027 lock-up
Co-founders of Korean drugmaker D&D Pharmatech have exercised stock options and agreed to lock up their shares until May 2027, a move the company says underscores confidence in its...
Kim Ji-hye
2026-06-04 2:12 PM
-
Bio
ENCell wins US clinical manufacturing contract for Ingenium’s NK cell therapy
ENCell, a contract development and manufacturing organization (CDMO) specializing in cell and gene therapies (CGTs) and novel drug development, said Thursday it has signed an addit...
Lee Han-soo
2026-06-04 11:17 AM
-
Pharma
Daewoong’s Envlo advances in 1st head-to-head SGLT-2 inhibitor trial
Daewoong Pharmaceutical said Thursday that it presented interim analysis results and the latest progress of the ENVELOP clinical study evaluating its novel diabetes treatment Envlo...
Lee Han-soo
2026-06-04 2:04 PM
-
Device/ICT
C&R Research lands US pivotal trial for Korea’s 1st insomnia DTx
C&R Research said Thursday that it has secured a contract to conduct a U.S. pivotal clinical trial for AIMneXt's digital therapeutic (DTx) Somzz, marking another step in the compan...
Kim Ji-hye
2026-06-04 10:40 AM
-
Hospital
AI communication agent targets hidden frustrations in pediatric ERs
A pediatric emergency room (ER) is a place where the intense anxiety of parents with sick children intersects with the overwhelming workload of medical professionals racing against...
Kim Eun-young
2026-06-04 3:40 PM
-
Life science
KRIBB team finds way to reverse chemotherapy resistance in colorectal cancer
A Korean research team has uncovered a critical mechanism behind chemotherapy resistance in colorectal cancer and proposed a new therapeutic strategy that could restore the effecti...
Lee Han-soo
2026-06-04 2:21 PM
-
Policy
Physician mayor Shin Sang-jin, nurse mayor Kim Bo-ra win re-election in local polls
Among healthcare professionals who ran for local government chief positions in the June 3 local elections, only Shin Sang-jin of the People Power Party (PPP), a physician and incum...
Kim Eun-young
2026-06-04 3:27 PM
-
Hospital
Ewha Seoul Hospital strengthens pediatric emergency care as Korea's care gap widens
A child’s fever at 2 a.m., a newborn in need of urgent surgery, or a toddler whose symptoms could point to a serious heart condition can quickly expose one of the weakest points in...
Lee Han-soo
2026-06-02 5:33 PM
-
K-Beauty
[Interview] Why natural rejuvenation is replacing the era of ‘filler face’
The paradigm of aesthetic dermatology is changing. The era of dramatic “volume enhancement,” in which sunken facial areas were artificially overfilled, is giving way to a clear mai...
Park Gi-taek
2026-06-02 3:05 PM
-
Pharma
ImmuneOncia reports 75% disease control rate for IMC-002 combo in TNBC at ASCO
ImmuneOncia Therapeutics presented data from a 12-patient phase 1b study showing a 75 percent disease control rate for its CD47 antibody candidate IMC-002 in combination with chemo...
Hong Sook
2026-06-02 1:46 PM
-
Policy
Health ministry to sharply raise delivery, NICU fees for maternal care centers
The Ministry of Health and Welfare (MOHW) has announced plans to significantly increase reimbursement rates for childbirth services and neonatal intensive care unit (NICU) admissio...
Kwak Sung-sun
2026-06-02 4:04 PM
-
Pharma
CEPI backs Moderna, IAVI, Oxford vaccines amid growing Bundibugyo Ebola outbreak
CEPI is moving to fast-track three investigational vaccine candidates against Bundibugyo ebolavirus as a rapidly expanding outbreak in the Democratic Republic of the Congo (DRC) an...
Lee Han-soo
2026-06-02 11:00 AM
-
Hospital
Foreign spending on liposuction at 365mc doubles as demand for body contouring rises
Foreign patients spent 12.5 billion won ($8.2 million) at 365mc, a Korean medical institution specializing in liposuction and body contouring procedures, in 2025, more than double ...
Kim Yoon-mi
2026-06-02 4:00 PM
-
Bio
CGBio launches 2nd filler brand in China through UPS BIO partnership
CGBio, a regenerative medicine and biotechnology company, said Tuesday that it has signed a strategic cooperation agreement with Chinese medical aesthetics specialist Zhejiang Ups ...
Lee Han-soo
2026-06-02 1:21 PM
-
Bio
FutureChem to raise ₩40 billion through rights offering to speed up global expansion
FutureChem is advancing a major growth initiative to accelerate the global commercialization of its radiopharmaceutical therapy (RPT) pipeline.The radiopharmaceutical drug develope...
Hong Sook
2026-06-02 1:43 PM
-
Bio
Oscotec’s cevidoplenib licensing deal puts spotlight on 1st-line ITP expansion potential
Oscotec’s recent licensing agreement with Agios Pharmaceuticals in the U.S. for cevidoplenib has renewed attention on the global development prospects of what has been viewed as th...
Hong Sook
2026-06-02 1:57 PM
-
K-Beauty
HK inno.N expands US beauty push with Olive Young Pasadena launch
HK inno.N said Tuesday that its slow-aging skincare brand bewants has launched on Olive Young's U.S. online store and at the retailer's first U.S. brick-and-mortar location in Pasa...
Kim Yoon-mi
2026-06-02 11:40 AM
-
Pharma
[ASCO 2026] Daraxonrasib emerges as the star of ASCO 2026 by winning a standing...
CHICAGO, Ill. – Kim Yun-mi / Korea Biomedical Review correspondent -- Among the studies presented during the Plenary Session at the 2026 American Society of Clinical Oncology (ASCO...
Kim Yun-mi
2026-06-02 3:31 PM
-
Pharma
Boryung completes Sanofi Taxotere takeover, launches global oncology biz
Boryung said Tuesday that it has completed the acquisition of global business rights to Sanofi's Taxotere (docetaxel) and officially begun worldwide commercialization of the chemot...
Kim Yoon-mi
2026-06-02 10:50 AM
-
Hospital
[Interview] 'First-line esophageal cancer treatment has changed since...
The treatment landscape for metastatic esophageal cancer in Korea is evolving following the inclusion of immunotherapy-based combination regimens under national health insurance co...
Hong Sook
2026-06-02 3:35 PM
-
Pharma
Onconic files Jaqbo NDA in India after phase 3 success in erosive GERD
Onconic Therapeutics is advancing the global rollout of its novel acid-suppression drug Jaqbo, filing for regulatory approval in India after making progress in China last year.The ...
Lee Han-soo
2026-06-02 11:32 AM
-
Pharma
Daewoong partners with Chime Biologics on Dupixent biosimilar
Daewoong Pharmaceutical said Tuesday it has partnered with Chinese CDMO Chime Biologics to develop, manufacture and commercialize a biosimilar of Dupixent (dupilumab), expanding it...
Lee Han-soo
2026-06-02 1:14 PM
-
Bio
SK bioscience wins 1st UNICEF influenza vaccine contract
SK bioscience said Tuesday it has secured its first influenza vaccine supply contract with UNICEF, a United Nations agency that procures and distributes vaccines for children, mark...
Lee Han-soo
2026-06-02 9:28 AM
-
K-Beauty
OliX raises ₩110 bil. from L'Oréal venture fund and Weiss Asset Management
OliX Pharmaceuticals, an RNA interference-based therapeutics company, said Tuesday that it has secured 110 billion won (about $72.7 million) through a private placement, attracting...
Lee Han-soo
2026-06-02 9:56 AM
-
Bio
Samsung creates ₩200 bil. fund to invest in global biotech ventures
Samsung Biologics said Monday it has established the third Samsung Life Science Fund, a 200 billion won ($145 million) venture investment vehicle backed by Samsung C&T, Samsung Bio...
Lee Han-soo
2026-06-01 5:31 PM
-
Pharma
BMS Korea invites applicants for 2026 Seoul-BMS Innovation Challenge
BMS Korea said Monday that it is accepting applications for the "2026 Seoul-BMS Innovation Challenge," an open innovation program jointly organized with the Seoul Metropolitan Gove...
Lee Han-soo
2026-06-01 4:05 PM
-
Pharma
Celltrion files for approval of Cosentyx biosimilar, CT-P55, in Canada
Celltrion announced on Monday that it has submitted a regulatory application to Health Canada for CT-P55, its biosimilar candidate to Cosentyx (secukinumab), a blockbuster treatmen...
Kim Ji-hye
2026-06-01 3:57 PM
-
Bio
Helixmith platform-based gene therapy wins 1st Chinese approval for non-viral DNA...
Helixmith said Monday that its Chinese partner, Beijing Northland Biotech, has received marketing approval from China's National Medical Products Administration (NMPA) for NL003, a...
Park Gi-taek
2026-06-01 3:41 PM
-
Pharma
Lilly Korea to launch higher-dose Mounjaro pens on June 10
Lilly Korea will launch the 12.5 mg and 15 mg doses of Mounjaro (tirzepatide) in a single-use prefilled pen format in Korea on June 10, expanding treatment options for patients who...
Lee Han-soo
2026-06-01 4:52 PM
-
Pharma
HK inno.N completes phase 3 trial of Korea's 1st JAK-1 inhibitor for canine atopic...
HK inno.N said Monday that it has successfully completed a phase 3 clinical trial of IN-115314, an oral treatment for atopic dermatitis in companion dogs, and has submitted an appl...
Lee Han-soo
2026-06-01 1:41 PM
-
Bio
Samsung Bioepis, Samsung Medical Center partner on AI-driven drug research
Samsung Bioepis and Samsung Medical Center (SMC) signed a joint research agreement last Friday to strengthen next-generation biomedical research capabilities.Under the agreement, t...
Lee Han-soo
2026-06-01 3:54 PM
-
Pharma
Lilly bets $1.26 billion on Hanmi's long-acting GLP-2 drug for short bowel syndrome
Eli Lilly has agreed to pay Korea's Hanmi Pharmaceutical up to $1.26 billion for global rights to sonefpeglutide, a long-acting GLP-2 (glucagon-like peptide-2) analog, deepening th...
Kim Ji-hye
2026-06-01 11:34 AM
-
Pharma
GSK secures Omjjara reimbursement in Korea, expanding access for myelofibrosis...
GSK Korea said Monday that its myelofibrosis treatment Omjjara (momelotinib hydrochloride hydrate) has been granted reimbursement coverage under Korea's national health insurance p...
Lee Han-soo
2026-06-01 1:59 PM
-
Device/ICT
NEXT BIOMEDICAL taps Terumo Europe to distribute Nexsphere-F in EMEA markets
NEXT BIOMEDICAL said Monday it has signed a distribution agreement with Terumo Europe for Nexsphere-F, its embolic microsphere product, in select countries across Europe, the Middl...
Lee Han-soo
2026-06-01 3:13 PM
-
Pharma
Daewoong promotes Baroezet as treatment option for low- to moderate-risk...
Daewoong Pharmaceutical said Monday that it has successfully concluded a series of launch symposiums for Baroezet, its combination therapy for dyslipidemia containing pitavastatin ...
Lee Han-soo
2026-06-01 3:51 PM
-
Device/ICT
Olympus Korea holds ‘Going-on Walk’ environmental campaign with cancer...
Olympus Korea, the Korean subsidiary of global medical technology company Olympus, announced that it partnered with the Korean Cancer Society to host its ESG social contribution pr...
Lee Han-soo
2026-06-01 3:07 PM
-
K-Beauty
Hugel’s WELLAGE enters Olive Young’s US store as North America push gains pace
Hugel’s clinical cosmetics brand WELLAGE has entered Olive Young’s first U.S. offline store in Pasadena, California, marking its first brick-and-mortar retail foothold in the U.S. ...
Lee Han-soo
2026-06-01 1:29 PM
-
Pharma
Samjin Pharm, AriBioLab forge strategic alliance for vaccine development
Samjin Pharmaceutical said it signed a memorandum of understanding last Friday with AriBioLab Vaccine Institute, a biotechnology company developing next-generation vaccines and imm...
Kim Ji-hye
2026-06-01 2:20 PM
-
Life science
Brain, immune system to drive next wave of medical devices: KAIST professor
As healthcare shifts from treating age-related decline to promoting longevity and rejuvenation, medical devices capable of analyzing and managing the human brain and immune system ...
Kwon Min-seon
2026-06-01 1:14 PM
-
Bio
[ASCO 2026] Korea’s 1st approved advanced cell therapy shows potential in rare...
CHICAGO, Ill. -- Kim Yun-mi / Korea Biomedical Review correspondent -- A novel cell therapy strategy aimed at preventing relapse rather than treating recurrence has shown promising...
Kim Yun-mi
2026-06-01 11:41 AM
-
Pharma
AbbVie, Pfizer win broader reimbursement for oral JAK inhibitors in Korea
Two oral Janus kinase inhibitors from AbbVie Korea and Pfizer Korea gained broader reimbursement in Korea on Monday, expanding treatment options for patients with ankylosing spondy...
Lee Han-soo
2026-06-01 11:09 AM
-
Opinion
[Column] Where is AI taking hospitals?
Hospitals are entering a period of transformation that goes far beyond the adoption of new technologies.Traditionally, hospitals have operated on the foundations of human experienc...
Choi Soo-young
2026-06-01 10:36 AM
-
Bio
Korea and UK race on hantavirus shots as Andes coverage stays in doubt
When the MV Hondius, a Dutch expedition cruise ship, docked at an enclosed section of the Port of Rotterdam on May 18, it carried 27 crew members, a skeleton medical team, and the ...
Kim Ji-hye
2026-05-29 8:07 PM